Find Academic Supervisors

Minh Q. Phan is an Associate Professor of Engineering at Dartmouth College's Thayer School of Engineering. His expertise spans system identification, iterative learning control, model predictive control, robotic swarm control, and intelligent control systems. He holds a BS from the University of California, Berkeley, and MS/M.Phil/PhD degrees from Columbia University in Mechanical Engineering. Dr. Phan has contributed to over 50 peer-reviewed publications and serves as an Associate Editor for the Journal of Guidance, Control, and Dynamics. His research focuses on advancing control theory applications in robotics, structural health monitoring, and sustainable construction materials. Key contributions include the development of OKID (Observer/Kalman Filter Identification) methods and bilinear system identification frameworks. Education History: Bachelor of Science in Mechanical Engineering, UC Berkeley, 1985 Master of Science in Mechanical Engineering, Columbia University, 1986 Master of Philosophy in Mechanical Engineering, Columbia University, 1988 Doctor of Philosophy in Mechanical Engineering, Columbia University, 1989 Research Interests: Advanced control methodologies for dynamic systems Model-based predictive control strategies Applications in robotics and aerospace engineering Structural health monitoring via system identification Machine learning for materials science Teaching Responsibilities include courses like ENGG 149 (Systems Identification), ENGS 145 (Modern Control Theory), and ENGG 148 (Structural Mechanics). His work bridges theoretical control systems with practical industrial applications, including automation in food processing and sustainable construction practices. Dr. Phan has collaborated on projects addressing viral epidemiology in Vietnam and coastal erosion mitigation strategies.

• System Identification
• Control Theory
• Robotics
• +4 more

Didier Trono is a Full Professor at École Polytechnique Fédérale de Lausanne (EPFL), where he leads the Laboratory of Virology and Genetics (LVG) within the School of Life Sciences. Formerly, from 2004 to 2012, he served as the founding dean of EPFL's Faculty of Life Sciences, orchestrating its development and growth during this formative period. Trono received his medical education at the University of Geneva, followed by clinical training in pathology, internal medicine, and infectious diseases in Geneva and at Massachusetts General Hospital in Boston. His scientific career began at the Whitehead Institute of MIT, and in 1990 he was recruited by the Salk Institute of San Diego to launch an AIDS research center. After seven years in the United States, he returned to Europe and eventually joined EPFL. Dr. Trono's research has evolved significantly over his career. Initially focusing on virus-host interactions, he studied pathogens like HIV and Hepatitis B virus, creating HIV-derived genetic transfer tools that are now successfully used in gene therapy. For approximately the last fifteen years, his research has centered on epigenetics, particularly exploring the impact of retroelements and their control mechanisms on development and physiology of higher organisms, including humans. His laboratory investigates how transposable elements and KRAB zinc finger proteins regulate gene expression, with important implications for understanding cancer biology and developing new diagnostic and therapeutic approaches. Analysis of his recent publications (2022-2024) reveals a strong focus on transposable elements, KRAB zinc finger proteins, and their roles in gene regulation and cancer. His work combines molecular biology, genomics, and bioinformatics approaches to understand how these ancient viral remnants have been co-opted by the host genome to regulate development and cellular functions. The research spans basic molecular mechanisms to potential clinical applications in cancer diagnosis and therapy, with some recent work also addressing SARS-CoV-2 and immune responses. Throughout his career, Professor Trono has mentored numerous PhD students, including Bojkowska Karolina, Brandão Sanches Vong Martins Filipe Amândio, Bulliard Yannick, Coluccio Andrea, Corsinotti Andrea, Coudray Alexandre, De Tribolet-Hardy Jonas Caspar, and Dorschel Iris Arianna. His laboratory has received significant funding to support research at the intersection of virology, genetics, and epigenetics, contributing to EPFL's reputation as a leading institution in life sciences research. The Trono Laboratory continues to be at the forefront of research on retroelements and their regulatory mechanisms, maintaining a vibrant research environment that bridges fundamental biological questions with potential medical applications, particularly in cancer research and precision medicine.

• Epigenetics
• Retroelements
• Transposable elements
• +5 more

Professor Maria Craig is a distinguished academic and researcher at the University of New South Wales, Faculty of Medicine & Health, specializing in childhood diabetes research. She holds a prominent position as a Professor with extensive contributions to the field of pediatric endocrinology and diabetes, particularly focusing on type 1 diabetes in children. Professor Craig's educational background includes: MB BS from the University of Melbourne MMedSc(ClinEpid) from the University of Newcastle PhD from the University of Sydney FRACP (Fellow of the Royal Australasian College of Physicians) Professor Craig's research primarily focuses on childhood diabetes, with special emphasis on prediction and prevention of type 1 diabetes. She has a significant interest in the association between viruses and type 1 diabetes, collaborating with the Virology Research Group at Prince of Wales Hospital (POWH). Together with Professor Bill Rawlinson, she leads the viral theme for the multicentre ENDIA study (endia.org.au). As principal investigator for the CoRD trial, she is conducting a world-first phase 1 study using autologous cord blood for prevention of type 1 diabetes in children with islet autoimmunity. Additionally, she serves as principal investigator for the Australasian Diabetes Data Network (ADDN). Her research portfolio also encompasses the epidemiology of various forms of childhood diabetes (type 1, type 2, cystic fibrosis related diabetes and monogenic diabetes) and diabetes complications, in collaboration with Professor Kim Donaghue at the Children's Hospital at Westmead. Professor Craig's extensive publication record, including over 361 journal articles, demonstrates her leadership in advancing our understanding of childhood diabetes. Her recent work shows increasing focus on early detection methods, risk prediction models, technological interventions for diabetes management, and the complex interplay between viral infections and autoimmune diabetes development. She has been instrumental in developing clinical practice guidelines through her role as co-editor of the International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines. Professor Craig has received numerous prestigious awards recognizing her contributions to pediatric endocrinology and diabetes research: Australian Paediatric Endocrine Group Young Investigator's Award (1997) Asia Pacific Paediatric Endocrine Society Clinical Teaching Award (2008) Lifetime Honorary Member, Caring and Living as Neighbours (2013) Australian Diabetes Society Jeff Flack Diabetes Data Award (2019) Australian Paediatric Endocrine Group Norman Wettenhall Award for Research and Innovation (2019) Throughout her career, Professor Craig has demonstrated exceptional leadership in professional societies, having served as former president/treasurer of the Australasian Paediatric Endocrine Group (APEG) and currently as Scientific Convenor of the Asia Pacific Paediatric Endocrine Society Fellows school. Her work with the ENDIA study and Australasian Diabetes Data Network represents significant collaborative research efforts involving multiple institutions across Australia and internationally. Her principal investigator roles for major studies indicate substantial research funding support. Professor Craig leads several important research initiatives including the ENDIA study, the CoRD trial, and the Australasian Diabetes Data Network. These programs involve multidisciplinary teams of researchers, clinicians, and support staff working collaboratively to advance understanding and treatment of childhood diabetes. Her work at the intersection of virology and diabetes represents a unique and innovative approach to understanding the environmental triggers of type 1 diabetes.

• Childhood Diabetes
• Type 1 Diabetes
• Virology and Diabetes
• +4 more

Harris H. Wang is an Associate Professor in the Department of Systems Biology and Department of Pathology and Cell Biology at Columbia University's Vagelos College of Physicians and Surgeons, where he also serves as Interim Chair of Systems Biology. He is affiliated with the Center for Computational Biology and Bioinformatics (C2B2) and the Integrated Program in Cellular, Molecular and Biomedical Studies (CMBS). B.S., Physics and Mathematics, MIT Ph.D., Biophysics, Harvard University Dr. Wang's research lies at the intersection of systems and synthetic biology, focusing on developing foundational technologies for genome engineering, microbiome manipulation, and synthetic genomics. His lab pioneers methods such as MAGE, MAGIC, CAST, and CAMII to enable high-throughput genetic manipulation, in situ microbiome engineering, and AI-driven microbial culturomics. Key research themes include understanding microbial community dynamics, engineering cellular memory systems, designing biocontained genetic circuits, and applying synthetic biology to human health challenges in personalized medicine and infectious disease. His recent publications reveal a strong trend in spatial and functional metagenomics, CRISPR-based microbiome editing, and synthetic biology tools for data storage and genetic stability. The articles span high-impact journals like Nature , Science , and Nature Biotechnology , reflecting his leadership in developing scalable, programmable biological systems. Scientific Awards: NIH Director’s Early Independence Award Forbes 30 Under 30 in Science Sloan Research Fellowship NSF CAREER Award ONR Young Investigator Award Burroughs Wellcome Fund PATH Award Schaefer Scholar Blavatnik National Award Vilcek Prize PECASE Dr. Wang has advised numerous PhD and postdoctoral researchers, many of whom have gone on to independent scientific careers. His lab is supported by major grants from NIH, NSF, DARPA, DOE, and foundations including the Bill & Melinda Gates Foundation and CZ Biohub NY. He is actively involved in educational initiatives, including organizing Columbia’s iGEM team and the Cold Spring Harbor Laboratory Synthetic Biology course. The Wang Lab is based at the Columbia University Irving Medical Center and is part of national consortia such as the Engineering Biology Research Consortium (EBRC) and the Genome Project-Write (GP-Write) initiative. The lab develops and applies cutting-edge technologies in automation, machine learning, and synthetic biology to engineer microbiomes for applications in medicine, global health, and climate change.

• Systems Biology
• Synthetic Biology
• Genome Engineering
• +17 more

Thomas Walz, PhD, is a Professor at The Rockefeller University and Head of the Laboratory of Molecular Electron Microscopy. Previously, he held positions as Assistant, Associate, and Professor at Harvard Medical School (1999–2015) and was an Investigator at the Howard Hughes Medical Institute (2008–2015). He earned his PhD and BS in biophysics from the University of Basel, Switzerland, and completed postdoctoral research at the University of Sheffield. Walz completed his education at the Biozentrum, University of Basel, Switzerland, where he received his Diploma in Biophysics (1992) and PhD in Biophysics (1996). He furthered his training as a postdoctoral researcher at the University of Sheffield (1996–1999). His research focuses on understanding membrane-related processes and the structural biology of membrane proteins in lipid environments. Utilizing cryo-electron microscopy and nanodisc technology, he investigates how lipid bilayers influence membrane protein structure and function. Key areas include mechanosensitive channels, T-cell receptor dynamics, and telomere maintenance mechanisms. Collaborations with the de Lange lab explore the CST-Polα/primase complex's role in telomere regulation. Walz has been recognized with the Genzyme Award for Outstanding Achievement in Biomedical Sciences (2004) and continues to contribute to advancements in structural biology and membrane protein research. While specific student advisees are not listed, Walz actively mentors through his roles in the David Rockefeller Graduate Program and Tri-Institutional programs. His research is supported by grants and institutional funding, though specific grants are not detailed here. He directs the Laboratory of Molecular Electron Microscopy at Rockefeller, a hub for innovative structural biology and membrane protein studies. The lab collaborates widely, integrating cryo-EM with electrophysiology and molecular dynamics simulations.

• Membrane Biology
• Structural Biology
• Cryo-electron Microscopy
• +5 more

Rolf Halden is a Professor and Center Director at Arizona State University, holding appointments in the School of Sustainable Engineering and the Built Environment, the Biodesign Center for Environmental Health Engineering, and the Global Futures Scientists and Scholars program. He is a leading expert in environmental health engineering, wastewater-based epidemiology, and bioremediation. Education: Ph.D. in Civil (Environmental) Engineering, University of Minnesota (1997) M.S. in Civil (Environmental) Engineering, University of Minnesota (1994) M.S. in Biology, Technical University of Braunschweig, Germany (1992) Postdoctoral Fellow, Environmental Science, Lawrence Livermore National Laboratory (1998) Research Focus: Halden’s research integrates environmental chemistry, public health, and sustainability to understand how anthropogenic chemicals affect ecological and human health. His lab uses advanced mass spectrometry (LC-MS/MS, MALDI-TOF) to track pollutants such as PPCPs, microplastics, pesticides, and dioxins across air, water, soil, and biological systems. He pioneered the use of wastewater treatment plants as public health observatories, enabling real-time tracking of disease, drug use, and environmental exposures. Scientific Awards & Recognition: Leadership Award, Arizona State University (2018) Rocky Mountain Emmy Award (2018) Leroy E. Burney Lecturer, Johns Hopkins School of Public Health (2011) ACS Expert Program Member (2014–present) NIEHS Superfund R01 Working Group National Leader (2012–2014) Labs & Teams: Halden is the Founding Director of the Biodesign Center for Environmental Health Engineering at ASU, where he leads a multidisciplinary team focused on environmental proteomics, bioremediation, and diagnostic tool development. He also co-leads the Human Health Observatory , a national wastewater monitoring network. Grants & Funding: Halden has secured major funding from NSF, NIH, EPA, DoD, and private industry. Notable projects include the development of in-situ groundwater monitoring devices, national wastewater surveillance of SARS-CoV-2, and studies on microplastics and neurodegenerative disease.

• Environmental Health Engineering
• Wastewater-Based Epidemiology
• Bioremediation
• +7 more

Sriram Subramaniam is a Professor in the Department of Biochemistry and Molecular Biology at the University of British Columbia (UBC) and holds the Gobind Khorana Canada Excellence Research Chair in Precision Cancer Drug Design. His research leverages cryo-electron microscopy (cryo-EM) to advance structural biology and drug design, focusing on protein dynamics and therapeutic target identification. Education: PhD in Physical Chemistry (1987) from Stanford University; MSc in Chemistry (1981) from Indian Institute of Technology, Kanpur. Subramaniam's interdisciplinary work combines cryo-EM with computational tools and molecular biology to study protein structures at atomic resolution. His lab has pioneered cryo-EM applications in precision medicine, including mapping small molecule drugs on patient-specific cancer mutants. Recent publications (2024-2022) highlight his contributions to understanding SARS-CoV-2 immune evasion, structural mechanisms of ATPases, and AI integration in structural biology. His research spans viral entry mechanisms, CRISPR systems, and neurodegenerative disease pathways. Scientific Awards: Gobind Khorana Canada Excellence Research Chair NIH Director’s Award for Scientific Excellence Fellow of the Biophysical Society Breakthrough Prize nomination Based at the Djavad Mowafaghian Center for Brain Health, Subramaniam leads the Program in Cryo-EM Guided Drug Design, contributing to over 177 peer-reviewed publications with a career h-index of 58 and citations exceeding 12,340.

• cryo-electron microscopy
• structural biology
• drug-design
• +4 more

Syed Hani Hassan Abidi is an Associate Professor at the Department of Biomedical Sciences , School of Medicine , Nazarbayev University , Kazakhstan. His research integrates virology , immunology , viral oncology , and bioinformatics , with a focus on HIV molecular epidemiology , viral evolution , and drug resistance . He has led international projects across Pakistan, Kenya, Afghanistan, and Kazakhstan, and is recognized for innovative teaching and MOOC development. Education: PhD in Virology and Immunology Research Interests: His laboratory employs bioinformatics (machine learning, AI), genomics , and proteomics to study HIV phylodynamics , viral co-infections , and oncogenic viruses like EBV in prostate cancer. He also explores microbiome-immunity interactions and designs antiviral drugs/vaccines . Recent Research Trends: His 2025 publications emphasize COVID-19 immunopathology , HIV/syphilis epidemiology in Pakistan , and particle physics contributions via ATLAS , showcasing interdisciplinary impact. Awards & Recognition: Outstanding Teachers Award (2019, Aga Khan University) Fellowship of Higher Education (UK, 2022) Teaching & Grants: He pioneered Pakistan’s first MOOC on Computer-Based Drug Discovery (2014) and received a 2022 SoTL grant for MOOC-based molecular biology education. His teaching integrates animations , films , and flipped classrooms . Collaborations & Labs: Leads projects on HIV drug resistance , HCV genomics in Kazakhstan , and AI-driven dementia diagnostics (Kazakh Brain Atlas). His lab collaborates with global institutions to advance viral disease surveillance and therapeutic innovation .

• Virology
• Immunology
• Viral Oncology
• +7 more

Osman Yağan is a Research Professor in the Department of Electrical and Computer Engineering at Carnegie Mellon University (CMU), with affiliate faculty status in the School of Computer Science. He is also a core member of CyLab Security and Privacy Institute. Prior to joining CMU in 2013, he was a Postdoctoral Research Fellow at CyLab. He holds a Ph.D. in Electrical and Computer Engineering from the University of Maryland (2011) and a B.S. from Middle East Technical University (2007). His research focuses on modeling, analysis, and optimization of computing systems, leveraging applied probability, network science, data science, and machine learning. Key areas include multi-armed bandits, resilient machine learning, contagion processes in networks, and cybersecurity. Research Interests include Machine Learning, Data Science, Network Science, Cybersecurity, and Robustness in Cyber-Physical Systems. He has advised numerous students, including current PhD candidates Yurun Tian, Orkun İrsoy, and Ishank Juneja, as well as notable alumni such as Mansi Sood (now at MIT) and Jun Zhao (Assistant Professor at Nanyang Technological University). Key Awards include the CIT Dean's Early Career Fellowship, IBM Academic Award, and Best Paper Awards at ICC 2021, IPSN 2022, and ASONAM 2023. His work spans theoretical contributions (e.g., contagion models in multi-layer networks) and applied research (e.g., mitigating cascading failures in power systems). He leads or co-leads grants from ONR, NSF, and ARO, focusing on resilient machine learning, network robustness, and pandemic modeling.

• Machine Learning
• Data Science
• Network Science
• +7 more

Prof. Dr. Jörg E. Drewes is a Full Professor and Chair at the Research Institute for Urban Water Management, Technical University of Munich (TUM), Germany. He also serves as Academic Program Director for Environmental Engineering at TUM and is a co-founder of Waterloop Solutions GmbH. His work spans advanced water treatment technologies, wastewater reuse, and environmental health surveillance. Affiliations : TUM, Colorado School of Mines, King Abdullah University of Science and Technology, UNSW Water Research Centre Research focuses on advanced oxidation processes , membrane fouling mitigation , micropollutant removal , and wastewater epidemiology for public health. His team develops integrated systems for water-energy-food nexus applications and graphene oxide-based treatment solutions. Recent publications address PFAS remediation , UVC-LED pre-treatment for biofouling control, and GIS-based wastewater surveillance models . Awards include the Bayerische Staatsmedaille (2023) and William Dunbar Medal (2022). 2023 : Bayerische Staatsmedaille 2022 : William Dunbar Medal 2018 : IWA Fellow He leads the Nexus@TUM initiative and contributes to EU water resilience strategies. Collaborations include projects in Germany, China, India, and Spain, focusing on climate-resilient water systems and resource recovery .

• Advanced water treatment processes
• Membrane processes
• Ozonation
• +13 more

Zaw Myo TUN is a Research Fellow (Adjunct) at the Saw Swee Hock School of Public Health, National University of Singapore, and serves as Senior Manager (Research and Evaluation) at IRD Global Singapore. His academic career includes roles such as Postdoctoral Fellow (2022) and Research Associate (2013–2021) at the same school. He holds a PhD from NUS (2016–2021), an MSc in Epidemiology from the London School of Hygiene & Tropical Medicine (2011–2012), and an MBBS from the University of Medicine, Mandalay, Myanmar (2003–2008). His research focuses on epidemiology, global health, tuberculosis vaccines, and public health policy. Key interests include maternal vaccination coverage in low-resource settings, hospital-acquired infections (e.g., MRSA), antibiotic resistance, and the ethical implications of pandemic control measures. He has contributed to studies on SARS-CoV-2 transmission dynamics, road traffic injury patterns in Bhutan, and malaria drug policy compliance in India. His publications analyze public perceptions of health policies, such as during the COVID-19 pandemic, and explore factors influencing healthcare behaviors in diverse populations. His work bridges clinical data (e.g., electronic medical records) and population-level health surveillance to inform evidence-based interventions. While no awards are explicitly mentioned, his research has addressed critical global health challenges like tuberculosis control in Myanmar and antimicrobial stewardship in Singapore primary care settings. Zaw Myo TUN’s career emphasizes translational research, linking academic findings to real-world health system improvements. His roles span academia and non-profit sectors, reflecting a commitment to addressing public health disparities through collaborative, policy-driven solutions.

• Epidemiology
• Global Health
• Tuberculosis Vaccines
• +3 more

Federica Tomao is an Associate Professor at the Department of Maternal, Child and Urological Sciences within Sapienza University of Rome. She actively teaches and supervises courses in Medicine and Surgery , Nursing , and Midwifery programs across multiple institutions. Current faculty member with academic rank Teaching roles in 6th, 3rd, and 2nd year courses Specialized in gynecologic oncology Research Focus : Her work spans ovarian cancer, breast cancer, and endometrial cancer, emphasizing chemotherapy optimization, precision medicine, and radiomics. Notably, she contributes to understanding PARP inhibitors, immune checkpoint therapies, and fertility preservation techniques in cancer survivors. Recent Publications highlight advancements in sarcopenia analysis, BRCA testing, and radiogenomic nomograms. These studies demonstrate her commitment to bridging imaging and molecular data for improved cancer management. Email : federica.tomao@uniroma1.it

• Gynecologic Oncology
• Ovarian Cancer
• Breast Cancer
• +5 more

Roles & Affiliations: Ikhlas Khan serves as Director of the National Center for Natural Products Research (NCNPR), Distinguished Professor, and Research Professor of Pharmacognosy at the University of Mississippi's School of Pharmacy. He also leads the FDA Program and coordinates natural products research across multiple initiatives, including the Sino-US TCM Research Center and the Center for Research of Indian Systems of Medicine (CRISM). Education: B.Sc. Chemistry (1980) - Aligarh Muslim University, India M.Sc. Organic Chemistry (1982) - Aligarh Muslim University, India Ph.D. Pharmacy (1987) - Ludwig-Maximilians-Universität, Munich Postdoctoral Studies - Swiss Federal Institute of Technology (ETH), Zurich Research Focus: Dr. Khan specializes in natural products research with emphasis on: Phytomedicine: Standardization of herbal products via analytical fingerprinting, pesticide/herbicide residue analysis, and bioanalytical quality control. Drug Discovery: Isolation of bioactive natural products, development of analytical methods for phytochemical characterization, and chiral separation techniques. Metabolism Studies: Role of metabolism in drug/natural product activity, particularly in aminoquinoline antimalarials. His work bridges academia, industry, and regulatory bodies, shaping policies for botanical supplements. Key Contributions: Over 850 peer-reviewed publications and leadership in high-impact projects like the FDA Center of Excellence. His lab pioneered methods to combat herbal product adulteration and safety issues. Awards & Recognition: UM Distinguished Professor Award (2018) Wiley Award (AOAC International, 2018) Qihuang International Prize (2017) Honoris Causa Doctorate (University of Hamdard, 2012) Labs & Collaborations: Directs the NCNPR, a global leader in natural products research, and collaborates with institutions worldwide. His team develops technologies for herbal product authentication and drug metabolism studies.

• Natural Products Research
• Phytomedicine
• Herbal Product Standardization
• +7 more

Frank Corsetti is a Professor of Earth Sciences at the University of Southern California (USC), leading the Corsetti Lab. His research focuses on the co-evolution of Earth and its biosphere, particularly during extreme events like the 'Snowball Earth' glaciation and mass extinctions. He holds a Ph.D. in Geological Sciences from UC Santa Barbara (1998) and a B.S. in Geology from UC Davis (1989). Research Interests: Corsetti studies geobiological processes such as stromatolite formation, microbial carbonate systems, and the environmental impacts of mass extinctions. His lab investigates biosignatures, diagenetic processes, and astrobiological applications. Current projects include the end-Triassic mass extinction and microbial interactions in extreme environments. Advising & Grants: He mentors a team of PhD students (including Reena Joubert, Alison Cribb, and others) and has secured funding from NASA for projects like stromatolite carbonate formation studies. His work bridges paleontology, geochemistry, and microbiology, contributing to understanding Earth’s long-term climate and life history. Labs/Teams: The Corsetti Lab at USC explores stromatolites, microbial mats, and ancient Earth systems. Collaborations involve institutions like JPL and international universities.

• Climate Science
• Geobiology
• Geochemistry
• +3 more

Peter Brodersen is a Professor at the Department of Biology, University of Copenhagen , specializing in Bioinformatics and RNA Biology . His research focuses on RNA modification (m6A), YTHDF proteins, and small RNA pathways in plants. Recent research trends from his group include: (1) molecular mechanisms of ARGONAUTE-small RNA interactions, (2) m6A-YTHDF regulatory systems in plant development, and (3) RNAi-independent roles of DICER-LIKE proteins in antiviral defense. Collaborations span Denmark and international institutions. Publications highlight cross-disciplinary work bridging computational biology and experimental plant genetics. Key subfields include RNA structure, epigenetic regulation, and antiviral immunity.

• RNA Biology
• Bioinformatics
• Plant Molecular Biology
• +4 more